Atlas Capital Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.67K Hold
445
﹤0.01% 873
2025
Q4
$3.19K Buy
+445
New +$3.52K ﹤0.01% 827
2025
Q2
$4.37K Hold
451
﹤0.01% 820
2025
Q1
$6.71K Sell
451
-3,095
-87% -$47.6K ﹤0.01% 829
2024
Q4
$52.9K Sell
3,546
-20,625
-85% -$336K 0.01% 601
2024
Q3
$462K Buy
24,171
+21,928
+978% +$455K 0.07% 234
2024
Q2
$46.4K Buy
2,243
+2,147
+2,236% +$42.7K 0.01% 601
2024
Q1
$1.8K Sell
96
-55
-36% -$944 ﹤0.01% 811
2023
Q4
$2.18K Sell
151
-84
-36% -$1.14K ﹤0.01% 828
2023
Q3
$4.08K Hold
235
﹤0.01% 772
2023
Q2
$4.89K Sell
235
-14
-6% -$304 ﹤0.01% 785
2023
Q1
$5.86K Sell
249
-101
-29% -$2.71K ﹤0.01% 784
2022
Q4
$9.78K Sell
350
-30
-8% -$767 ﹤0.01% 731
2022
Q3
$8.89K Hold
380
﹤0.01% 726
2022
Q2
$12.8K Sell
380
-5
-1% -$175 ﹤0.01% 729
2022
Q1
$13.4K Hold
385
﹤0.01% 672
2021
Q4
$11.7K Hold
385
﹤0.01% 698
2021
Q3
$12.6K Hold
385
﹤0.01% 693
2021
Q2
$11.7K Buy
+385
New +$12.7K ﹤0.01% 719

Other funds holding OGN

Atlas Capital Advisors's OGN Position: Q1 2026 in Review

Atlas Capital Advisors held its Organon & Co (OGN) position steady in Q1 2026 at 445 shares worth $2.67K. The position accounts for ﹤0.01% of the portfolio, ranked #873.

Atlas Capital Advisors first reported a position in OGN in Q2 2021 and has held it in 19 quarters since. The position peaked at $462K in Q3 2024. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Atlas Capital Advisors held 445 shares of Organon & Co worth $2.67K as of Q1 2026.
  • Atlas Capital Advisors left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of Atlas Capital Advisors's portfolio in Q1 2026, its #873 holding.
  • Atlas Capital Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 19 quarters since.
  • Atlas Capital Advisors's Organon & Co position peaked at $462K in Q3 2024.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Atlas Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.